US 7718779
Prophylactic and therapeutic monoclonal antibodies
granted A61KA61K2039/505
Quick answer
US patent 7718779 (Prophylactic and therapeutic monoclonal antibodies) held by The United States of America as represented by the Secretary of the Army expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505